Showing results (1-10 of 220) with videos related to
Sort By:
Pageof 22
The International Journal of Biological Markers|April 6, 2001
Circulating angiogenesis regulators in cancer patientsK Kuroi, M ToiOncology Reports|February 22, 2001
Circulating levels of endostatin in cancer patientsK Kuroi, C Tanaka, M ToiBreast Cancer (Tokyo, Japan)|December 15, 2000
The predictive value of angiogenesis for adjuvant therapy in breast cancerM Toi, H Bando, K KuroiInternational Journal of Oncology|June 16, 2001
Clinical significance of plasma nucleosome levels in cancer patientsK Kuroi, C Tanaka, M ToiGan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2000
[Antiangiogenesis therapy and hormone therapy--their resemblance and applications of prognostic and predictive factors]M Toi, G Matsumoto, H Bando, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 10, 1999
[Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline]S Nagai, M Toi, K Kuroi, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 2, 2006
Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancerK Kuroi, M Toi, H Tsuda, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1991
[Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients]A Osaki, M Toi, H Yamada, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 4, 2001
[Efficacy of weekly docetaxel therapy for advanced or recurrent breast cancer]K Kuroi, H Bando, S Nagai, et al.American Journal of Surgery|October 1, 1992
Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patientsA Osaki, M Toi, H Yamada, et al.Pageof 22